Search Results 1571-1580 of 14716 for anti-TNF drugs

1. Mayo Clinic researchers study new class of drugs to treat multiple myeloma

   She says that bispecific antibodies represent a new class of immunotherapy drugs based on similar technology as CAR-T cell therapy, but it uses off-the-shelf ...

2. Overview - Skeletal Development and Regeneration Research Laboratory - Mayo Clinic Research

   D., of Mayo Clinic, and a. Validating new treatment targets. Work in our lab is revealing novel insights into numerous musculoskeletal diseases, with a goal of ...

3. Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. - Mayo Clinic

   Systemic anti-lymphoma therapy within 28 days or use of antibody agents within 8 weeks use of radioimmunotherapy within 3 months; Known seropositive for or ...

4. Anabolic Steroid (Oral Route, Parenteral Route) Before Using - Mayo Clinic

   It is not known whether anabolic steroids pass into breast milk. Drug Interactions. Although certain medicines should not be used together at all, in other ...

5. Bictegravir, Emtricitabine, And Tenofovir Alafenamide (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Biktarvy. Descriptions. Bictegravir, emtricitabine ...

6. Altretamine (Oral Route) Precautions - Mayo Clinic

   While you are being treated with altretamine, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's ...

7. Butalbital, Acetaminophen, Caffeine, And Codeine (Oral Route) Description and Brand Names - Mayo Clinic

   It has also been used for migraine headaches. Codeine belongs to the group of medicine called narcotic analgesics (pain medicines). It acts on the central ...

8. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

   Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy. Print details. Share; Facebook · Twitter.

9. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

   Pancreatic ductal adenocarcinoma is one of the most aggressive types of cancer. In the absence of early detection methods and effective treatment, ...

10. An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

    Subjects receiving anti-angiogenic drugs (e.g., anti-vascular endothelial growth factor [VEGF]); Chronic exposure to cytotoxic therapy for oncologic or ...